# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-140697
Filing Date
2023-05-10
Accepted
2023-05-10 16:04:10
Documents
97
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d464631d10q.htm iXBRL | 10-Q | 1915681
2 | EX-10.1 | d464631dex101.htm | EX-10.1 | 3224
3 | EX-31.1 | d464631dex311.htm | EX-31.1 | 10333
4 | EX-31.2 | d464631dex312.htm | EX-31.2 | 10318
5 | EX-32 | d464631dex32.htm | EX-32 | 4307
11 | GRAPHIC | g464631g66p75.jpg | GRAPHIC | 35356
12 | GRAPHIC | g464631teva2.jpg | GRAPHIC | 6543
| Complete submission text file | 0001193125-23-140697.txt |  | 10523372

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20230331.xsd | EX-101.SCH | 89206
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20230331_cal.xml | EX-101.CAL | 47660
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20230331_def.xml | EX-101.DEF | 565090
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20230331_lab.xml | EX-101.LAB | 583427
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20230331_pre.xml | EX-101.PRE | 596100
91 | EXTRACTED XBRL INSTANCE DOCUMENT | d464631d10q_htm.xml | XML | 2083509

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 23906255
SIC: 2834 Pharmaceutical Preparations